148 related articles for article (PubMed ID: 26117189)
1. In vitro dissolution-permeation evaluation of an electrospun cyclodextrin-based formulation of aripiprazole using μFlux™.
Borbás E; Balogh A; Bocz K; Müller J; Kiserdei É; Vigh T; Sinkó B; Marosi A; Halász A; Dohányos Z; Szente L; Balogh GT; Nagy ZK
Int J Pharm; 2015 Aug; 491(1-2):180-9. PubMed ID: 26117189
[TBL] [Abstract][Full Text] [Related]
2. Electrospun polycaprolactone nanofibers as a potential oromucosal delivery system for poorly water-soluble drugs.
Potrč T; Baumgartner S; Roškar R; Planinšek O; Lavrič Z; Kristl J; Kocbek P
Eur J Pharm Sci; 2015 Jul; 75():101-13. PubMed ID: 25910438
[TBL] [Abstract][Full Text] [Related]
3. Investigation and Mathematical Description of the Real Driving Force of Passive Transport of Drug Molecules from Supersaturated Solutions.
Borbás E; Sinkó B; Tsinman O; Tsinman K; Kiserdei É; Démuth B; Balogh A; Bodák B; Domokos A; Dargó G; Balogh GT; Nagy ZK
Mol Pharm; 2016 Nov; 13(11):3816-3826. PubMed ID: 27611057
[TBL] [Abstract][Full Text] [Related]
4. Bioequivalence prediction with small-scale biphasic dissolution and simultaneous dissolution-permeation apparatus-An aripiprazole case study.
Kádár S; Kennedy A; Lee S; Ruiz R; Farkas A; Tőzsér P; Csicsák D; Tóth G; Sinkó B; Borbás E
Eur J Pharm Sci; 2024 Jul; 198():106782. PubMed ID: 38697313
[TBL] [Abstract][Full Text] [Related]
5. Fast Dissolving Oral Drug Delivery System Based on Electrospun Nanofibrous Webs of Cyclodextrin/Ibuprofen Inclusion Complex Nanofibers.
Celebioglu A; Uyar T
Mol Pharm; 2019 Oct; 16(10):4387-4398. PubMed ID: 31436100
[TBL] [Abstract][Full Text] [Related]
6. Enhanced dissolution, permeation and oral bioavailability of aripiprazole mixed micelles: In vitro and in vivo evaluation.
Piazzini V; Landucci E; Urru M; Chiarugi A; Pellegrini-Giampietro DE; Bilia AR; Bergonzi MC
Int J Pharm; 2020 Jun; 583():119361. PubMed ID: 32334067
[TBL] [Abstract][Full Text] [Related]
7. Drug permeation through biomembranes: cyclodextrins and the unstirred water layer.
Loftsson T
Pharmazie; 2012 May; 67(5):363-70. PubMed ID: 22764564
[TBL] [Abstract][Full Text] [Related]
8. Modulation of release rate and barrier transport of Diclofenac incorporated in hydrophilic matrices: role of cyclodextrins and implications in oral drug delivery.
Miro A; Rondinone A; Nappi A; Ungaro F; Quaglia F; La Rotonda MI
Eur J Pharm Biopharm; 2009 May; 72(1):76-82. PubMed ID: 19135532
[TBL] [Abstract][Full Text] [Related]
9. Pharmaceutical applications of cyclodextrins: effects on drug permeation through biological membranes.
Loftsson T; Brewster ME
J Pharm Pharmacol; 2011 Sep; 63(9):1119-35. PubMed ID: 21827484
[TBL] [Abstract][Full Text] [Related]
10. Cyclodextrin-water soluble polymer ternary complexes enhance the solubility and dissolution behaviour of poorly soluble drugs. Case example: itraconazole.
Taupitz T; Dressman JB; Buchanan CM; Klein S
Eur J Pharm Biopharm; 2013 Apr; 83(3):378-87. PubMed ID: 23201048
[TBL] [Abstract][Full Text] [Related]
11. Cyclodextrin and phospholipid complexation in solubility and dissolution enhancement: a critical and meta-analysis.
Semalty A
Expert Opin Drug Deliv; 2014 Aug; 11(8):1255-72. PubMed ID: 24909802
[TBL] [Abstract][Full Text] [Related]
12. The artificial membrane insert system as predictive tool for formulation performance evaluation.
Berben P; Brouwers J; Augustijns P
Int J Pharm; 2018 Feb; 537(1-2):22-29. PubMed ID: 29241703
[TBL] [Abstract][Full Text] [Related]
13. Combining strategies to optimize a gel formulation containing miconazole: the influence of modified cyclodextrin on textural properties and drug release.
Ribeiro AM; Figueiras A; Freire C; Santos D; Veiga F
Drug Dev Ind Pharm; 2010 Jun; 36(6):705-14. PubMed ID: 20050726
[TBL] [Abstract][Full Text] [Related]
14. Microwave-generated bionanocomposites for solubility and dissolution enhancement of poorly water-soluble drug glipizide: in-vitro and in-vivo studies.
Kushare SS; Gattani SG
J Pharm Pharmacol; 2013 Jan; 65(1):79-93. PubMed ID: 23215691
[TBL] [Abstract][Full Text] [Related]
15. Solid dispersions, part I: recent evolutions and future opportunities in manufacturing methods for dissolution rate enhancement of poorly water-soluble drugs.
Bikiaris DN
Expert Opin Drug Deliv; 2011 Nov; 8(11):1501-19. PubMed ID: 21919807
[TBL] [Abstract][Full Text] [Related]
16. Cyclodextrins in drug delivery.
Loftsson T; Jarho P; Másson M; Järvinen T
Expert Opin Drug Deliv; 2005 Mar; 2(2):335-51. PubMed ID: 16296758
[TBL] [Abstract][Full Text] [Related]
17. Cyclodextrins and Drug Membrane Permeation: Thermodynamic Considerations.
Sripetch S; Prajapati M; Loftsson T
J Pharm Sci; 2022 Sep; 111(9):2571-2580. PubMed ID: 35487262
[TBL] [Abstract][Full Text] [Related]
18. Cyclodextrin-containing poly(ethyleneoxide) tablets for the delivery of poorly soluble drugs: potential as buccal delivery system.
Cappello B; De Rosa G; Giannini L; La Rotonda MI; Mensitieri G; Miro A; Quaglia F; Russo R
Int J Pharm; 2006 Aug; 319(1-2):63-70. PubMed ID: 16650700
[TBL] [Abstract][Full Text] [Related]
19. Skin permeation study of dehydroepiandrosterone (DHEA) compared with its alpha-cyclodextrin complex form.
Ceschel GC; Mora PC; Lombardi Borgia S; Maffei P; Ronchi C
J Pharm Sci; 2002 Nov; 91(11):2399-407. PubMed ID: 12379925
[TBL] [Abstract][Full Text] [Related]
20. Third generation solid dispersions of ferulic acid in electrospun composite nanofibers.
Yu DG; Yang JM; Branford-White C; Lu P; Zhang L; Zhu LM
Int J Pharm; 2010 Nov; 400(1-2):158-64. PubMed ID: 20713138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
